Novel anti-EGFR antibody-drug conjugate AVID100: A phase 2a trial in patients with EGFR-overexpressing advanced solid tumors Melear, J., Lakhani, N., O'Shaughnessy, J. A., Wilks, S. T., Khan, S., Chandana, S. R., Tolcher, A. W., Papadopoulos, K. P., Cole, Y., Rivas, K., Ghosh, R., Sinclair, S., Lutz, R., Nadler, P. I., Wood, D. L., Burtness, B. AMER ASSOC CANCER RESEARCH. 2019

View details for DOI 10.1158/1535-7163.TARG-19-A088

View details for Web of Science ID 000510047200076